SEC Form 4 · accession 0001209191-16-146354
Sarepta Therapeutics, Inc. · SRPT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Sandesh Mahatme
Officer — Senior Vice President, CFO
Period of report
Oct 17, 2016
Accepted (ET)
Oct 19, 2016 · 4:22 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000873303
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 17, 2016 | M | 30,000 | $13.90 | A | 61,532 | D | |
| Common StockF1 | Oct 17, 2016 | S | 30,000 | $50.0834 | D | 31,532 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Options (right to buy)F1 | $13.90 | Oct 17, 2016 | M | 30,000 | D | Feb 27, 2016 | Feb 27, 2025 | Common Stock | 30,000 | 19,874 | D |
Explanation of responses
- F1This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person, on September 15, 2016, accordingly, the reporting person had no discretion with regards to the timing of the transaction.